Web Stats Provided By Google Analytics

Thursday, September 5, 2013

GSK experimental cancer vaccine disappoints in melanoma trial

An experimental cancer vaccine from GlaxoSmithKline failed to help melanoma patients in a closely watched late-stage clinical trial, dealing a blow to the high-risk, high-reward project.

http://www.foxnews.com/health/2013/09/05/gsk-experimental-cancer-vaccine-disappoints-in-melanoma-trial/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+foxnews%2Fhealth+%28Internal+-+Health+-+Text%29

No comments:

Post a Comment